Wainua is administered subcutaneously once every four weeks [1]. The recommended dosage is 200 mg [1].
How is Wainua supplied?
Wainua is available as a solution for subcutaneous injection [1]. Each carton contains two single-dose vials, with each vial holding 200 mg of Wainua in 1.3 mL of solution [1].
What is Wainua used to treat?
Wainua is a medication used to reduce the risk of cardiovascular events in adults with established atherosclerotic cardiovascular disease (ASCVD) and hyperlipidemia or mixed dyslipidemia [1]. It is an injectable medication that works by lowering low-density lipoprotein cholesterol (LDL-C) levels [1].
How does Wainua work?
Wainua is a novel oral lipid-lowering drug that targets APOA2, a protein involved in cholesterol transport [1]. By inhibiting APOA2, Wainua increases the expression of PCSK9 in the liver. PCSK9 is a protein that reduces the number of LDL receptors on the surface of liver cells. With more LDL receptors, the liver can clear more LDL cholesterol from the blood, thereby lowering LDL-C levels [1].
What are the potential side effects of Wainua?
The most common side effects reported in clinical trials for Wainua include injection site reactions, upper respiratory tract infections, and headache [1].
What should I tell my doctor before starting Wainua?
Before starting Wainua, you should inform your doctor about any other medical conditions you have and all medications you are taking, including prescription drugs, over-the-counter medicines, vitamins, and herbal supplements [1]. It is also important to discuss any history of liver problems or kidney disease [1].
Are there any contraindications for Wainua?
Wainua should not be used by individuals with a known hypersensitivity to the drug or any of its ingredients [1].
What is the availability and pricing of Wainua?
Wainua has received regulatory approval in the United States [2]. Pricing information for Wainua is typically available through the manufacturer or specialty pharmacies upon request [1, 2].
What are similar treatments for high cholesterol?
Other medications used to manage hyperlipidemia include statins, ezetimibe, PCSK9 inhibitors (e.g., evolocumab, alirocumab), bile acid sequestrants, and fibrates [3]. The choice of treatment depends on individual patient factors, including the severity of hyperlipidemia, existing cardiovascular disease, and response to other therapies [3].
What is the patent status of Wainua?
Information regarding the patent status and exclusivity of Wainua can be found on resources like DrugPatentWatch.com [4]. DrugPatentWatch.com tracks patent filings, approvals, and expiry dates for pharmaceutical products.
---
Sources:
[1] Wainua Prescribing Information. https://www.drugpatentwatch.com/drugs/wainua
[2] https://www.drugpatentwatch.com/drugs/wainua/approvals
[3] https://www.drugpatentwatch.com/drugs/categories/hyperlipidemia
[4] https://www.drugpatentwatch.com/